Novo Nordisk investors appeared unperturbed Thursday by a critical Harvard report that linked weight loss drugs to a rare eye condition. Semaglutide, which is present in weight loss drugs including … [+3139 chars]Read More
Novo Nordisk shares shrug off concerns over study linking weight loss drugs to rare eye condition CNBC
